tirzepatide 3ml Flex-Dose 3 mL Injectable 10 mg/mL Unboxing my new Tirzepatide ✨,

Getting enough medication through the skin to produce a meaningful clinical effect is a significant scientific hurdle

you may not be receiving a therapeutically meaningful dose via the sublingual route

Tirzepatide can cause gastrointestinal issues like diarrhea, vomiting, constipation, and stomach pain

In the SURPASS-2 trial published in the New England Journal of Medicine, tirzepatide at 15 mg produced an average weight loss of 11.2 kg compared to 5.7 kg with semaglutide 1 mg over 40 weeks

With a focus on safety, visible results and accessibility, the team uses only US FDA and approved technology, applies a holistic view to beauty and wellness, and avoids hard-selling or pressure tactics